Efficacy of Ranibizumab in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion: Results From the Sham-Controlled ROCC Study
Authors:
- 1 September 2010
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 150 (3) , 310-314
Abstract
No abstract availableKeywords
Funding Information
- Novartis Ophthalmic Inc
- Novartis Ophthalmic Inc
This publication has 18 references indexed in Scilit:
- Retinal artery occlusion following intravitreal anti‐VEGF therapyActa Ophthalmologica, 2010
- Intravitreal bevacizumab (Avastin(R)) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trialBritish Journal of Ophthalmology, 2008
- Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein OcclusionsOphthalmology, 2008
- INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR CENTRAL AND HEMICENTRAL RETINAL VEIN OCCLUSIONSRetina, 2007
- Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2006
- A Pilot Study of Multiple Intravitreal Injections of Ranibizumab in Patients with Center-Involving Clinically Significant Diabetic Macular EdemaOphthalmology, 2006
- INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF MACULAR EDEMA IN CENTRAL RETINAL VEIN OCCLUSIONRetina, 2006
- Cataract Progression After Intravitreal Triamcinolone InjectionAmerican Journal of Ophthalmology, 2005
- Intravitreal triamcinolone acetonide and intraocular pressureAmerican Journal of Ophthalmology, 2004
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994